{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:19:29Z","timestamp":1790241569037,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["NCT04492618"],"award-info":[{"award-number":["NCT04492618"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["IRB-15-006427"],"award-info":[{"award-number":["IRB-15-006427"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["BU00217677"],"award-info":[{"award-number":["BU00217677"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["IRB 16-009397"],"award-info":[{"award-number":["IRB 16-009397"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["19-004087"],"award-info":[{"award-number":["19-004087"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","award":["BU00188778"],"award-info":[{"award-number":["BU00188778"]}],"id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jid.2023.11.027","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T22:50:53Z","timestamp":1708987853000},"page":"1994-2001.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-2916","authenticated-orcid":false,"given":"Angelina S.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-0166","authenticated-orcid":false,"given":"Jacob A.","family":"Kechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-8363","authenticated-orcid":false,"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-0818","authenticated-orcid":false,"given":"Alysia","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8650-3140","authenticated-orcid":false,"given":"Kevin J.","family":"Severson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-5530","authenticated-orcid":false,"given":"Blake","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-2996","authenticated-orcid":false,"given":"Puneet","family":"Bhullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6594-6143","authenticated-orcid":false,"given":"Shams","family":"Nassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-4574","authenticated-orcid":false,"given":"Miranda","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-4227","authenticated-orcid":false,"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6758-2875","authenticated-orcid":false,"given":"Richard J.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2240-6397","authenticated-orcid":false,"given":"Steven","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-6868","authenticated-orcid":false,"given":"Xianying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-5722","authenticated-orcid":false,"given":"Lam C.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-5923","authenticated-orcid":false,"given":"Samantha","family":"Zunich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-3220","authenticated-orcid":false,"given":"Aleksandar","family":"Sekulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-0294","authenticated-orcid":false,"given":"Mark","family":"Pittelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-1705","authenticated-orcid":false,"given":"Aaron","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.11.027_bib1","first-page":"1729","article-title":"Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: results of a pooled-analysis (N0993)","volume":"20","author":"Atherton","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jid.2023.11.027_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000328403","article-title":"Intralesional infliximab in noninfectious cutaneous granulomas: three cases of necrobiosis lipoidica","volume":"222","author":"Barde","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2023.11.027_bib3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/BF03348204","article-title":"Necrobiosis lipoidica diabeticorum: response to pentoxiphylline","volume":"26","author":"Basaria","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jid.2023.11.027_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000182259","article-title":"Photodynamic therapy of necrobiosis lipoidica--a multicenter study of 18 patients","volume":"218","author":"Berking","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2023.11.027_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ajd.13875","article-title":"Treatment of granuloma annulare with tofacitinib","volume":"63","author":"Bosch-Amate","year":"2022","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/745483","article-title":"Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis","volume":"2012","author":"Cavalcanti","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.jid.2023.11.027_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2023.11.027_bib8","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2023.11.027_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jdcr.2019.11.016","article-title":"Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid","volume":"6","author":"Damsky","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2023.11.027_bib10","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2023.11.027_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib12","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.11.027_bib13","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/jdv.16297","article-title":"Successful treatment of ulcerative necrobiosis lipoidica with Janus kinase inhibitor","volume":"34","author":"Erfurt-Berge","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.11.027_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.0007-0963.2004.05899.x","article-title":"Topical tacrolimus in granuloma annulare and necrobiosis lipoidica","volume":"150","author":"Harth","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jaad.2021.06.848","article-title":"Necrobiosis lipoidica-associated cutaneous malignancy","volume":"86","author":"Harvey","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamadermatol.2018.5635","article-title":"Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes","volume":"155","author":"Hashemi","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/ijd.16529","article-title":"Characteristics of ulcerated and non-ulcerated necrobiosis lipoidica","volume":"62","author":"Hines","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ijd.15960","article-title":"Ulcerated necrobiosis lipoidica successfully treated with tofacitinib","volume":"61","author":"Jan\u00dfen","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2105-15-224","article-title":"MAP-RSeq: Mayo analysis pipeline for RNA sequencing","volume":"15","author":"Kalari","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jid.2023.11.027_bib20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2133.2005.06762.x","article-title":"Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study","volume":"153","author":"Kreuter","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jid.2023.11.027_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamadermatol.2018.0756","article-title":"Improvement in ulcerative necrobiosis lipoidica after Janus kinase-inhibitor therapy for polycythemia Vera","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/annrheumdis-2019-215387","article-title":"Refractory sarcoidosis-like systemic granulomatosis responding to Ruxolitinib","volume":"78","author":"Levraut","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2023.11.027_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2023.11.027_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41590-021-00956-8","article-title":"The cellular architecture of the antimicrobial response network in human leprosy granulomas","volume":"22","author":"Ma","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2023.11.027_bib26","doi-asserted-by":"crossref","unstructured":"McPhie ML, Swales WC, Gooderham MJ. Improvement of granulomatous skin conditions with tofacitinib in three patients: a case report. SAGE Open Med Case Rep 2021;9:2050313X211039477.","DOI":"10.1177\/2050313X211039477"},{"key":"10.1016\/j.jid.2023.11.027_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2230.2005.01962.x","article-title":"Long-term results of topical PUVA in necrobiosis lipoidica","volume":"31","author":"Narbutt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/ijd.16856","article-title":"Treatment options for necrobiosis lipoidica: a systematic review","volume":"62","author":"Nihal","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2230.1993.tb00977.x","article-title":"Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline","volume":"18","author":"Noz","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdcr.2022.08.028","article-title":"Improvement of necrobiosis lipoidica with topical Ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream","volume":"29","author":"Nugent","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2023.11.027_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2023.11.027_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","article-title":"Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2023.11.027_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","article-title":"Visual analogue scale: evaluation of the instrument for the assessment of pruritus","volume":"92","author":"Reich","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2023.11.027_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2013.05.034","article-title":"Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options","volume":"69","author":"Reid","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jid.2023.11.027_bib37","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaad.2021.04.034","article-title":"Clinical and morphological features of necrobiosis lipoidica","volume":"86","author":"Severson","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jaad.2021.03.026","article-title":"Comorbidities and diabetic complications in patients with necrobiosis lipoidica","volume":"86","author":"Severson","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.11.027_bib39","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets [published correction appears in Nucleic Acids Res 2021;49:10800]","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2023.11.027_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2023.11.027_bib42","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","article-title":"Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2023.11.027_bib43","first-page":"187","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jid.2023.11.027_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int Rev Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X24001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:16:19Z","timestamp":1756685779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X24001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0022202X24001593"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.11.027","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}